Hans van der Vliet, MD PhD

Hans van der Vliet is a practicing medical oncologist and professor in medical oncology at the Amsterdam UMC, Cancer Center Amsterdam, The Netherlands. He received his MD from the University of Amsterdam in 1998 and his PhD (cum laude) from the VU University in Amsterdam in 2003 where he also received his medical training.

He performed post-doctoral research at the Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School and is the scientific founder and Chief Scientific Officer of LAVA Therapeutics, a NASDAQ listed clinical stage biotech company.